Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Colorado State University
M.D. Anderson Cancer Center
Hoffmann-La Roche
Cancer Research UK
Children's Oncology Group
BioInvent International AB
Essen Biotech
Azienda Ospedaliero-Universitaria di Parma
Institut Bergonié
Mayo Clinic
Incyte Corporation
Washington University School of Medicine
Incyte Corporation
University of Alabama at Birmingham
Seagen Inc.
Cyteir Therapeutics, Inc.
ModernaTX, Inc.
Celldex Therapeutics
UNICANCER
Stingthera, Inc.
Corvus Pharmaceuticals, Inc.
Hoffmann-La Roche
City of Hope Medical Center
Eisai Inc.
Scripps Health
Blue Note Therapeutics
Incyte Corporation
Hospices Civils de Lyon
AstraZeneca
Incyte Corporation
Celgene
Tocagen Inc.
Shenzhen BinDeBio Ltd.
Novartis
Celldex Therapeutics
Masonic Cancer Center, University of Minnesota
Amgen
OHSU Knight Cancer Institute
Ohio State University Comprehensive Cancer Center
University of Minnesota
Rutgers, The State University of New Jersey
Barbara Ann Karmanos Cancer Institute
Memorial Sloan Kettering Cancer Center
Eastern Cooperative Oncology Group
Valerio Therapeutics
Indiana University
University of Chicago
National Cancer Institute (NCI)
National Cancer Institute (NCI)